Also trades as: VVY.AS (AMS) · $vol 0M
0R3M.L LSE
Vivoryon Therapeutics N.V.
1W: +0.0%
1M: -2.7%
3M: -7.6%
YTD: -23.8%
1Y: -24.3%
3Y: -90.9%
€1.10 ($1.24)
+0.02 (+1.84%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
📊 Key Metrics
TTM€0M
Revenue
+100.0% YoY
€-19M
Net Income
+66.5% YoY
€-17M
Free Cash Flow
+62.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-247.7%
ROA-182.0%
ROIC1935.3%
Valuation
P/E-4.8
P/B20.8
EV/EBITDA-1.6
Leverage
Debt/Equity0.05
Current Ratio4.56
Interest Cov.-146.6x
Quality Scores
Piotroski F3/9
Altman Z-68.31
Beneish M0.00